Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Litecoin, ETF and SEC
LTC Price Soars 11% as Canary Litecoin ETF Advances
Litecoin (LTC) prices shot up 11% in the past 24 hours, printing a daily high of $131 and analyst predict $170 in the near future.
Canary Litecoin ETF Takes a Step Closer to Approval—SEC Invites Comments
Litecoin price surged 13% on Thursday followed by U.S. SEC formally acknowledging Canary Capital's application for a spot Litecoin ETF.
Litecoin Surges 11% As SEC Inches Closer To Canary Litecoin ETF Decision
Litecoin surged more than 11% in the last 24 hours as the US SEC moves closer to a decision on the Canary Litecoin ETF.
Litecoin price jumps 30% as SEC invites public comments on Canary’s LTC ETF filing
Canary Capital’s Litecoin exchange-traded fund is advancing towards possible approval as the US SEC invites public feedback before deciding whether to approve or reject the listing. Eric Balchunas@EricBalchunas·Follow First alt coin 19b-4 to be acknowledged,
Litecoin Spikes Over 11% After SEC Acknowledges ETF Filing—Market Regulator Says LTC 'Very Similar' To Bitcoin
Litecoin (CRYPTO: LTC) soared to double-digit gains on Wednesday after the SEC formally acknowledged its exchange-traded fund application. What happened: The regulator solicited comments on the ETF applied by digital asset trading firm Canary Capital and asked for those to be submitted 21 days after publication in the Federal Register.
SEC Logs Spot Litecoin ETF Filing from Canary Capital, Opens Comment Period
Canary's proposed Litecoin ETF aims to eliminate the technological hurdles that have historically irked mainstream investors.
SEC Asks Public To Comment On Proposed $LTC ETF, Pumping Litecoin Near $130
The SEC has "acknowledged" Canary Capital's filing for a Litecoin ETF, pushing $LTC prices higher and triggering a wave of excitement among Litecoin users who believe $LTC is the better coin than Bitcoin.
Is Litecoin Next? SEC Opens Comment Period for First Litecoin ETF Filing
The SEC has opened a 21-day public comment period for Canary Capital's Litecoin ETF proposal, which would offer traditional brokerage access to the cryptocurrency
SEC seeks public input on Canary Litecoin ETF proposal
The U.S. Securities and Exchange Commission (SEC) announced it is seeking public comments on a proposal for the Canary Litecoin Exchange-Traded Fund (ETF). This move is a step forward in the potential approval or disapproval process by the agency.
17h
Canary Capital's ETF Plans Took Shape Thanks to Trump
Valkyrie founder and CEO Steven McClurg, Canary quickly filed back-to-back applications for four crypto-related ...
blockonomi
2h
Litecoin (LTC) Price: Surges 15% as ETF Speculation Intensifies
Litecoin's 15% price increase to $125.90 was driven by positive FOMC meeting outcomes, potential ETF developments, and ...
CoinDesk
13d
Why Litecoin Might Be the Next Crypto to Get Its ETF
Canary Funds’ litecoin ETF filings were recently amended, potentially indicating that the SEC is engaging with the filing.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Crash at Reagan airport
Los Angeles wildfire updates
Loses freedom of speech suit
Pentagon agency halts events
Ex-FDNY chief pleads guilty
Drops classified docs case
Lawsuit to keep records
FDA upgrades recall
'The Voice' alum dies at 44
Bird flu 'widespread' in MA
Record trade deficit in goods
Signs Laken Riley Act
1st Latina, Black AZ justice
Gets 11 years in prison
Witkoff meets Netanyahu
OpenAI probing DeepSeek
Agrees to settle Trump suit
Fall behind in reading
To lay off 234 workers
Pushes for earlier trial
OK school citizenship rule
Lay's potato chips recall
To recall 290K+ vehicles
Cutting corporate workforce
Denver schools face probe
Recalls chicken nuggets
NC inmate escapes
Rescinds freeze on grants
Security detail revoked
Approved for kidney disease
Feedback